Amicus Therapeutics Total Assets 2007-2019 | FOLD

Amicus Therapeutics total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Amicus Therapeutics Annual Total Assets
(Millions of US $)
2018 $790
2017 $627
2016 $1,037
2015 $908
2014 $210
2013 $128
2012 $110
2011 $70
2010 $113
2009 $85
2008 $129
2007 $167
2006 $60
2005 $0
Amicus Therapeutics Quarterly Total Assets
(Millions of US $)
Q2 2019 $918
Q1 2019 $765
Q4 2018 $790
Q3 2018 $839
Q2 2018 $826
Q1 2018 $870
Q4 2017 $627
Q3 2017 $681
Q2 2017 $939
Q1 2017 $993
Q4 2016 $1,037
Q3 2016 $918
Q2 2016 $914
Q1 2016 $863
Q4 2015 $908
Q3 2015 $987
Q2 2015 $404
Q1 2015 $193
Q4 2014 $210
Q3 2014 $125
Q2 2014 $118
Q1 2014 $112
Q4 2013 $128
Q3 2013 $69
Q2 2013 $82
Q1 2013 $93
Q4 2012 $110
Q3 2012 $118
Q2 2012 $112
Q1 2012 $121
Q4 2011 $70
Q3 2011 $79
Q2 2011 $90
Q1 2011 $103
Q4 2010 $113
Q3 2010 $64
Q2 2010 $75
Q1 2010 $88
Q4 2009 $85
Q3 2009 $99
Q2 2009 $109
Q1 2009 $116
Q4 2008 $129
Q3 2008 $143
Q2 2008 $151
Q1 2008 $160
Q4 2007 $167
Q3 2007 $125
Q2 2007 $132
Q1 2007 $0
Q3 2006 $0
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.493B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.342B 13.25
Gilead Sciences (GILD) United States $84.042B 10.32
CSL (CSLLY) Australia $72.428B 0.00
Celgene (CELG) United States $69.903B 10.81
Vertex Pharmaceuticals (VRTX) United States $44.326B 47.90
Illumina (ILMN) United States $43.735B 51.38
Biogen (BIIB) United States $42.849B 7.61
Regeneron Pharmaceuticals (REGN) United States $31.212B 14.17
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.275B 12.80
SINO PHARMACEUT (SBMFF) China $17.750B 0.00
Incyte (INCY) United States $16.360B 48.15
Exact Sciences (EXAS) United States $14.074B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.065B 0.00
Genmab (GNMSF) Denmark $12.366B 69.36
Seattle Genetics (SGEN) United States $11.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.249B 0.00
Galapagos (GLPG) Belgium $8.775B 0.00
QIAGEN (QGEN) Netherlands $7.685B 25.24
Bio-Techne Corp (TECH) United States $7.575B 52.33
Guardant Health (GH) United States $7.163B 0.00
Sarepta Therapeutics (SRPT) United States $6.540B 0.00
BeiGene (BGNE) Cayman Islands $6.319B 0.00
Amarin (AMRN) Ireland $5.983B 0.00
Exelixis (EXEL) United States $5.834B 15.16
Bluebird Bio (BLUE) United States $5.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.655B 0.00
Moderna (MRNA) United States $5.415B 0.00
Horizon Pharma Public (HZNP) Ireland $4.928B 12.53
ARGENX SE-ADR (ARGX) Netherlands $4.772B 0.00
Ascendis Pharma (ASND) Denmark $4.406B 0.00
Repligen (RGEN) United States $4.071B 79.01
Spark Therapeutics (ONCE) United States $4.066B 0.00
China Biologic Products (CBPO) China $3.934B 24.56
Blueprint Medicines (BPMC) United States $3.880B 0.00
Medicines (MDCO) United States $3.852B 0.00
MorphoSys AG (MOR) Germany $3.692B 0.00
Alkermes (ALKS) Ireland $3.554B 0.00
Mirati Therapeutics (MRTX) United States $3.329B 0.00
Immunomedics (IMMU) United States $3.018B 0.00
Emergent Biosolutions (EBS) United States $2.794B 41.97
Genomic Health (GHDX) United States $2.710B 50.82
CRISPR Therapeutics AG (CRSP) Switzerland $2.626B 0.00
Arena Pharmaceuticals (ARNA) United States $2.620B 5.63
Ultragenyx Pharmaceutical (RARE) United States $2.578B 0.00
Reata Pharmaceuticals (RETA) United States $2.564B 0.00
MyoKardia (MYOK) United States $2.541B 0.00
Acceleron Pharma (XLRN) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.413B 0.00
NeoGenomics (NEO) United States $2.342B 125.28
Intercept Pharmaceuticals (ICPT) United States $2.226B 0.00
Myriad Genetics (MYGN) United States $2.040B 21.41
Cambrex (CBM) United States $2.010B 25.41
Zai Lab (ZLAB) China $1.964B 0.00
Akcea Therapeutics (AKCA) United States $1.957B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.855B 23.45
UniQure (QURE) Netherlands $1.838B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Insmed (INSM) United States $1.696B 0.00
REGENXBIO (RGNX) United States $1.456B 0.00
Coherus BioSciences (CHRS) United States $1.391B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.369B 0.00
Alector (ALEC) United States $1.346B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.345B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Sangamo Therapeutics (SGMO) United States $1.285B 0.00
RA PHARMCTL INC (RARX) United States $1.178B 0.00
Innoviva (INVA) United States $1.176B 3.39
AnaptysBio (ANAB) United States $1.159B 0.00
Fate Therapeutics (FATE) United States $1.141B 0.00
Epizyme (EPZM) United States $1.105B 0.00
Athenex (ATNX) United States $1.085B 0.00
Zymeworks (ZYME) Canada $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.016B 0.00
Twist Bioscience (TWST) United States $0.941B 0.00
Cara Therapeutics (CARA) United States $0.921B 0.00
Principia Biopharma (PRNB) United States $0.882B 459.75
Arvinas (ARVN) United States $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.877B 14.64
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Codexis (CDXS) United States $0.829B 0.00
WAVE Life Sciences (WVE) Singapore $0.826B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.815B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.771B 0.00
Anika Therapeutics (ANIK) United States $0.756B 26.76
Cytokineticsorporated (CYTK) United States $0.739B 0.00
Zealand Pharma (ZEAL) Denmark $0.734B 8.51
Vericel (VCEL) United States $0.729B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.721B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
DBV Technologies S.A (DBVT) France $0.578B 0.00
Intra-Cellular Therapies (ITCI) United States $0.577B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
MiMedx (MDXG) United States $0.561B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.557B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Precision BioSciences (DTIL) United States $0.506B 0.00
Retrophin (RTRX) United States $0.504B 0.00
Heska (HSKA) United States $0.500B 64.82
Autolus Therapeutics (AUTL) United Kingdom $0.498B 0.00
Syros Pharmaceuticals (SYRS) United States $0.492B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.451B 0.00
CytomX Therapeutics (CTMX) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.424B 0.00
Agenus (AGEN) United States $0.422B 0.00
Arcus Biosciences (RCUS) United States $0.418B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.415B 0.00
Bellus Health (BLU) Canada $0.395B 0.00
Scholar Rock Holding (SRRK) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Adverum Biotechnologies (ADVM) United States $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.382B 0.00
Gritstone Oncology (GRTS) United States $0.365B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 26.25
Prothena (PRTA) Ireland $0.348B 0.00
Theratechnologies (THERF) Canada $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.319B 477.09
Albireo Pharma (ALBO) United States $0.318B 0.00
Clovis Oncology (CLVS) United States $0.312B 0.00
ADMA Biologics Inc (ADMA) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
Avid Bioservices (CDMO) United States $0.304B 0.00
Geron (GERN) United States $0.298B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Kindred Biosciences (KIN) United States $0.276B 0.00
MannKind (MNKD) United States $0.271B 0.00
PDL BioPharma (PDLI) United States $0.271B 6.97
Seres Therapeutics (MCRB) United States $0.270B 0.00
Prometic Life Sciences (PFSCF) Canada $0.266B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Senesco Technologies (ELOX) United States $0.258B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.257B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.256B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.251B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Spero Therapeutics (SPRO) United States $0.232B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Athersys (ATHX) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.215B 0.00
Kamada (KMDA) Israel $0.213B 8.12
Compugen (CGEN) Israel $0.210B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.202B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.195B 0.00
Affimed (AFMD) Germany $0.195B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
Acorda Therapeutics (ACOR) United States $0.185B 0.00
Arsanis (XFOR) United States $0.184B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
XOMA (XOMA) United States $0.168B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Emmaus Life Sciences (EMMA) United States $0.163B 0.00
Northwest Biotherapeutics (NWBO) United States $0.163B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.162B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 6.00
Dyadic (DYAI) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Novavax (NVAX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.096B 0.00
Arbutus Biopharma (ABUS) Canada $0.093B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Trevena (TRVN) United States $0.086B 0.00
Synlogic (SYBX) United States $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
OvaScience (MLND) United States $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.30
Curis (CRIS) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
AEterna Zentaris (AEZS) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.10
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00